Incorporation of Targeting Biomolecule Improves Interpolymer Complex-Superparamagnetic Iron Oxide Nanoparticles Attachment to and Activation of [T.sub.2] MR Signals in M2 Macrophages

Introduction: Inflammatory diseases are the leading cause of death in the world, accounting for 3 out of 5 deaths. Despite the abundance of diagnostic tools for detection, most screening and diagnostic methods are indirect and insufficient as they are unable to reliably discriminate between high-ris...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of nanomedicine 2023-01, Vol.17, p.473
Hauptverfasser: Nwasike, Chukwuazam, Purr, Erin, Nagi, Jaspreet Singh, Mahler, Gretchen J, Doiron, Amber L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction: Inflammatory diseases are the leading cause of death in the world, accounting for 3 out of 5 deaths. Despite the abundance of diagnostic tools for detection, most screening and diagnostic methods are indirect and insufficient as they are unable to reliably discriminate between high-risk or low-risk stages of inflammatory diseases. Previously, we showed that the selective activation of interpolymer complexed superparamagnetic iron oxide nanoparticles (IPC-SPIOs) under oxidative conditions can be detected by a change in [T.sub.2] magnetic resonance (MR) contrast. In this work, IPC-SPIOs were further modified by incorporating mannose as a targeting biomolecule to enhance nanoparticle delivery to M2 macrophages at inflammatory sites. Methods: Uncoated SPIOs were synthesized via coprecipitation from a mixture of Fe[Cl.sub.2] and Fe[Cl.sub.3], PEGylated by adsorbing PEG 300 kDa (40 mg/mL in water) to SPIOs (3 mg/mL in water) over 24 hours, and complexed by mixing 0.25 mg/mL aqueous poly(gallol) with 2 mg/mL PEG-SPIOs and adding 1 M of phosphate buffer in a 9:9:2 ratio. Mannose-PEG attachment was accomplished conducting a second complexation of mannose-PEG to IPC- SPIOs. M2 macrophages were treated with 150, 100, and 75 [micro]g/mL of IPC-SPIOs and mannose-IPC-SPIOs to investigate activation of [T.sub.2] MRI signals. Results and Discussion: Surface modification resulted in a slight reduction in ROS scavenging capacity; however, nanoparticle uptake by M2 macrophages increased by over 50%. The higher uptake did not cause a reduction in cellular viability. In fact, mannose-IPC-SPIOs induced significant [T.sub.2] MR contrast in M2 macrophages compared to IPC-SPIOs and nanoparticles exposed to M1 macrophages. M2 macrophages activated over 30% of mannose-IPC-SPIOs after 6 hours of exposure compared to Ml macrophages and untargeted M2 macrophages. These findings demonstrated that mannose- IPC-SPIOs specifically targeted M2 macrophages and scavenged cellular ROS to activate [T.sub.2] MR signal, which can be used to detect inflammation. Keywords: targeted nanoparticles, inflammatory diseases, MRI, contrast agents, mannose biomolecules
ISSN:1178-2013
DOI:10.2147/IJN.S392567